Tatiana N. Zabotina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tatiana N. Zabotina has a total of 217 co-authors. Here are the top co-authors by number of shared publications:
- Zaira G. Kadagidze
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
18 shared publications - Anna A. Borunova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
17 shared publications - Antonina I. Chertkova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
14 shared publications - Elena N. Zakharova
Blokhin National Medical Research Center of Oncology
13 shared publications - Dmitry Vyacheslavovich Tabakov
Federal State Budgetary Scientific Institution “Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies”, Moscow, Russia
9 shared publications - Esma K. Shoua
N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation
9 shared publications
Latest Publications
- Open Access
- 5 October 2026
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 25 (3) , 88-100
Immune profiles of peripheral blood and tumor tissue in molecular subtypes of breast cancer: correlation with soluble forms of programmed cell death-1 receptor and its ligand
Background. Molecular subtypes of breast cancer determine not only the biological behavior of the tumor, but also the nature of the antitumor immune response. However, the connection between T-lymphocyte subpopulations and the soluble forms of the programmed cell death 1 receptor (sPD-1) and its ligand (sPD-L1) is not well studied. Aim. To study the relationship of sPD-1 / sPD-L1 levels with the functional state of peripheral blood T-lymphocytes and the tumor microenvironment in various molecular subtypes of breast cancer. Materials and methods. The study included 63 patients with luminal B (HER2–) (HER2 – human epidermal growth factor receptor 2), luminal B (HER2+), non-luminal (HER2+), and triple negative breast cancer. Lymphocyte subpopulations were analyzed by flow cytometry and sPD-1 / sPD-L1 levels were determined by enzyme immunoassay. Results. In triple negative cancer, a profile of functionally competent cytotoxic T-lymphocytes was revealed with a strong negative correlation between the level of sPD-L1 and the proportion of CD8+perforin+ tumor-infiltrating lymphocytes (r = –0.975; p = 0.005). Luminal subtype B (HER2–) is characterized by signs of T cell depletion and a “cold” immune phenotype. Conclusion. Soluble forms of PD-1 / PD-L1 demonstrate subtype-specific correlations with the functional state of T-lymphocytes, which indicates their potential as prognostic biomarkers, especially in triple negative breast cancer.
- 5 October 2026
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 25 (3) , 88-100
Open AccessImmune profiles of peripheral blood and tumor tissue in molecular subtypes of breast cancer: correlation with soluble forms of programmed cell death-1 receptor and its ligand
Background. Molecular subtypes of breast cancer determine not only the biological behavior of the tumor, but also the nature of the antitumor immune response. However, the connection between T-lymphocyte subpopulations and the soluble forms of the programmed cell death 1 receptor (sPD-1) and its ligand (sPD-L1) is not well studied. Aim. To study the relationship of sPD-1 / sPD-L1 levels with the functional state of peripheral blood T-lymphocytes and the tumor microenvironment in various molecular subtypes of breast cancer. Materials and methods. The study included 63 patients with luminal B (HER2–) (HER2 – human epidermal growth factor receptor 2), luminal B (HER2+), non-luminal (HER2+), and triple negative breast cancer. Lymphocyte subpopulations were analyzed by flow cytometry and sPD-1 / sPD-L1 levels were determined by enzyme immunoassay. Results. In triple negative cancer, a profile of functionally competent cytotoxic T-lymphocytes was revealed with a strong negative correlation between the level of sPD-L1 and the proportion of CD8+perforin+ tumor-infiltrating lymphocytes (r = –0.975; p = 0.005). Luminal subtype B (HER2–) is characterized by signs of T cell depletion and a “cold” immune phenotype. Conclusion. Soluble forms of PD-1 / PD-L1 demonstrate subtype-specific correlations with the functional state of T-lymphocytes, which indicates their potential as prognostic biomarkers, especially in triple negative breast cancer.
- 15 July 2026
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 25 (2) , 64-71
Multiple myeloma: plasma cell immunophenotype and monitoring of minimal residual disease after induction therapy and autologous hematopoietic stem cell transplantation
Background. Minimal residual disease (MRD) is the presence of a tumor clone in the bone marrow that can prevent remission during treatment. The immunophenotype of MM cells may be different, so it is necessary to understand the spectrum of markers that allow differentiating abnormal plasma cells (PCs). Monitoring MRD can influence the choice of patient management tactics. Aim. Analysis of the immunophenotype of myeloma cells and assessment of the frequency of MRD during treatment. Materials and methods. The study included 56 MM patients, the average age was 55 years. Induction chemotherapy was carried out according to the VRD scheme (including lenalidomide, bortezomib, and dexamethasone), autologous hematopoietic stem cell transplantation (auto-HSCT). The MOB status was assessed by multicolored flow cytometry using a Becton Dickinson FACSCanto II cytofluorimeter (Becton Diskinson, USA), Kaluza Analysis v. 2.1 (Beckman Coulter, Inc., USA). Monoclonal antibodies of clusters of differentiation (CD) were used: CD45, CD19, CD27, CD56, CD28, CD38, CD117, CD19, CD81, immunoglobulin light chains κ / λ, nuclear dye 7-aminoactinomycin D (Becton Diskinson, USA). Results. The most common MM immunophenotype was aberrant in the absence of CD19 and CD27, reduced expression of CD38, and abnormal presence of CD56 was noted. There is aberrancy in CD27 / CD117 / CD81. Most often, the immunophenotype of PCs corresponded to CD19–CD45–CD56+, noted in 46.4 % of cases. The frequency of MRD negativity after induction therapy is 35.7 %, after auto-HSCT – 56.7 %. A 1.3-fold decrease in the number of PCs in the bone marrow after auto-HSCT was established. Conversion after auto-HSCT of MRD positive cases (before transplantation of PCs more than 0.01 %, but less than 0.1 %) was detected in 53 % of patients. Conclusion. The MRD status in MM is assessed based on the aberrant expression of the main and additional plasma cell markers. At the stage of induction therapy and after auto-HSCT, the MRD status differs and there is a conversion of MRD-positive cases to negative ones. Monitoring MRD can be useful for choosing the tactics of managing patients with MM.
- 15 July 2026
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 25 (2) , 64-71
Multiple myeloma: plasma cell immunophenotype and monitoring of minimal residual disease after induction therapy and autologous hematopoietic stem cell transplantation
Background. Minimal residual disease (MRD) is the presence of a tumor clone in the bone marrow that can prevent remission during treatment. The immunophenotype of MM cells may be different, so it is necessary to understand the spectrum of markers that allow differentiating abnormal plasma cells (PCs). Monitoring MRD can influence the choice of patient management tactics. Aim. Analysis of the immunophenotype of myeloma cells and assessment of the frequency of MRD during treatment. Materials and methods. The study included 56 MM patients, the average age was 55 years. Induction chemotherapy was carried out according to the VRD scheme (including lenalidomide, bortezomib, and dexamethasone), autologous hematopoietic stem cell transplantation (auto-HSCT). The MOB status was assessed by multicolored flow cytometry using a Becton Dickinson FACSCanto II cytofluorimeter (Becton Diskinson, USA), Kaluza Analysis v. 2.1 (Beckman Coulter, Inc., USA). Monoclonal antibodies of clusters of differentiation (CD) were used: CD45, CD19, CD27, CD56, CD28, CD38, CD117, CD19, CD81, immunoglobulin light chains κ / λ, nuclear dye 7-aminoactinomycin D (Becton Diskinson, USA). Results. The most common MM immunophenotype was aberrant in the absence of CD19 and CD27, reduced expression of CD38, and abnormal presence of CD56 was noted. There is aberrancy in CD27 / CD117 / CD81. Most often, the immunophenotype of PCs corresponded to CD19–CD45–CD56+, noted in 46.4 % of cases. The frequency of MRD negativity after induction therapy is 35.7 %, after auto-HSCT – 56.7 %. A 1.3-fold decrease in the number of PCs in the bone marrow after auto-HSCT was established. Conversion after auto-HSCT of MRD positive cases (before transplantation of PCs more than 0.01 %, but less than 0.1 %) was detected in 53 % of patients. Conclusion. The MRD status in MM is assessed based on the aberrant expression of the main and additional plasma cell markers. At the stage of induction therapy and after auto-HSCT, the MRD status differs and there is a conversion of MRD-positive cases to negative ones. Monitoring MRD can be useful for choosing the tactics of managing patients with MM.
- 30 April 2026
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 25 (1) , 94-102
Lymphoid populations and tumor disseminated cells in the bone marrow in early breast cancer
Background. The study of lymphoid populations is a necessary step for understanding the interaction between the tumor and the immune system, as well as for a detailed analysis of the persistence of tumor cells in the bone marrow of patients with breast cancer. Lymphoid populations of the bone marrow can serve as a potential point of application for immunotherapy. Aim. To study the composition of lymphoid populations and assess the relationship with disseminated tumor cells in the bone marrow of patients with operable breast cancer Materials and methods. The study included 65 bone marrow samples obtained by sternal puncture in patients with breast cancer. Ductal adenocarcinoma stage T1 / T2, N0 status prevailed. Luminal A was detected in 51.3 %, luminal B 10.3 %, Erb-B2 overexpressing subtype was established in 15.4 % and triple-negative subtype in 6.4 %. T cells (CD3), B cells (CD19), NK cells (CD56+CD3– ), minor populations of TCRγδ and TCRαβ lymphocytes, CD4+CD25+ T cells, subpopulations of CD10+, CD38+, CD5+ B cells were studied. CD45+EpCAM+ cells among myelokaryocytes of a bone marrow sample were assessed. An immunological study of bone marrow using monoclonal antibodies (Becton Diskinson, USA) was performed on a FACS Canto II flow cytometer. The results were analyzed using the Kaluza Analysis v.2.1 program. Results. A relationship was established between CD19+CD10+ cells and the morphological type of breast cancer: their increased content was noted in ductal adenocarcinoma (p ≤0.05). There was a relationship between lymphogenous metastasis and the level of CD5+CD38+ cells (p ≤0.05). In high-grade cancer, there was an increase in the proportion of CD4+CD25+ cells, estrogen-positive tumors were distinguished by the predominance of NK cells in the bone marrow (p ≤0.05). T-lymphoid populations are associated with the presence of disseminated tumor cells in the bone marrow. An increase in the proportion of CD4+CD25+ with a decrease in the number of CD3+HLA-DR+ and B-cells was noted (p = 0.03). Conclusion. Lymphoid populations of the bone marrow are associated with the morphological characteristics of breast cancer. In metastatic bone marrow lesions, the proportion of T-cell lymphoid populations changes and the number of B-cells decreases.
- 30 April 2026
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 25 (1) , 94-102
Lymphoid populations and tumor disseminated cells in the bone marrow in early breast cancer
Background. The study of lymphoid populations is a necessary step for understanding the interaction between the tumor and the immune system, as well as for a detailed analysis of the persistence of tumor cells in the bone marrow of patients with breast cancer. Lymphoid populations of the bone marrow can serve as a potential point of application for immunotherapy. Aim. To study the composition of lymphoid populations and assess the relationship with disseminated tumor cells in the bone marrow of patients with operable breast cancer Materials and methods. The study included 65 bone marrow samples obtained by sternal puncture in patients with breast cancer. Ductal adenocarcinoma stage T1 / T2, N0 status prevailed. Luminal A was detected in 51.3 %, luminal B 10.3 %, Erb-B2 overexpressing subtype was established in 15.4 % and triple-negative subtype in 6.4 %. T cells (CD3), B cells (CD19), NK cells (CD56+CD3– ), minor populations of TCRγδ and TCRαβ lymphocytes, CD4+CD25+ T cells, subpopulations of CD10+, CD38+, CD5+ B cells were studied. CD45+EpCAM+ cells among myelokaryocytes of a bone marrow sample were assessed. An immunological study of bone marrow using monoclonal antibodies (Becton Diskinson, USA) was performed on a FACS Canto II flow cytometer. The results were analyzed using the Kaluza Analysis v.2.1 program. Results. A relationship was established between CD19+CD10+ cells and the morphological type of breast cancer: their increased content was noted in ductal adenocarcinoma (p ≤0.05). There was a relationship between lymphogenous metastasis and the level of CD5+CD38+ cells (p ≤0.05). In high-grade cancer, there was an increase in the proportion of CD4+CD25+ cells, estrogen-positive tumors were distinguished by the predominance of NK cells in the bone marrow (p ≤0.05). T-lymphoid populations are associated with the presence of disseminated tumor cells in the bone marrow. An increase in the proportion of CD4+CD25+ with a decrease in the number of CD3+HLA-DR+ and B-cells was noted (p = 0.03). Conclusion. Lymphoid populations of the bone marrow are associated with the morphological characteristics of breast cancer. In metastatic bone marrow lesions, the proportion of T-cell lymphoid populations changes and the number of B-cells decreases.
- Open Access
- 17 December 2025
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 24 (4) , 19-30
Leptomeningeal breast cancer metastases: clinical and cytological features on the background of intrathecal methotrexate therapy
Background. Cytological examination of cerebrospinal fluid (CSF) and the dynamics of neurological symptoms are key in the diagnosis and evaluation of treatment effectiveness for leptomeningeal metastases. Quantitative assessment of circulating tumor cells in CSF is not routinely used. This study examined the correlation between the dynamics of tumor cell counts in CSF and the dynamics of neurological symptoms in patients with leptomeningeal metastases from breast cancer during intrathecal methotrexate therapy. Aim. To identify clinical and cytological features in patients with leptomeningeal metastases from breast cancer during intrathecal methotrexate therapy. Materials and methods. A retrospective analysis of 30 patients with leptomeningeal metastases from breast cancer who received intrathecal methotrexate in the Department of Neurooncology of the N. N. Blokhin National Medical Research Center of Oncology from 2018 to 2024. Results. All 30 cases involved women with ductal or lobular breast cancer. The highest proportion of patients with leptomeningeal metastases were found in stage III–C breast cancer (33.3 %). Cytological analysis of cerebrospinal fluid and neurological status assessment were performed before each methotrexate administration. The correlation was monitored throughout the treatment period. A direct statistically significant relationship has been found between the number of tumor cells in cerebrospinal fluid and the severity of neurological disorders: at one month after treatment start r = 0.702; p = 0.000 and at two months r = 0.819; p = 0.000. However, prior to therapy initiation there was no correlation between these parameters (r = 0.056; p = 0.770). Thus, with a low level of tumor cytosis pronounced neurological symptoms could be present (75 cells, symptom score – 6 points), while conversely, with an elevated cytosis level mild neurological manifestations might occur (400 cells, symptom score – 3 points). It was found that only with a decrease in the number of tumor cells in the cerebrospinal fluid by 2 or more times (or by 50 %) does the severity of neurological disorders change. And an increase in the severity of neurological disorders occurs in the case of an increase in the number of cells in the cerebrospinal fluid by 1.2 times (or by 20 %). Moreover, this correlation was maintained throughout the treatment. Conclusion. Evaluation of the dynamics of tumor cytosis in the cerebrospinal fluid, along with clinical characteristics, can be recommended for use in predicting the response to treatment in patients with leptomeningeal metastases of breast cancer.
- 17 December 2025
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 24 (4) , 19-30
Open AccessLeptomeningeal breast cancer metastases: clinical and cytological features on the background of intrathecal methotrexate therapy
Background. Cytological examination of cerebrospinal fluid (CSF) and the dynamics of neurological symptoms are key in the diagnosis and evaluation of treatment effectiveness for leptomeningeal metastases. Quantitative assessment of circulating tumor cells in CSF is not routinely used. This study examined the correlation between the dynamics of tumor cell counts in CSF and the dynamics of neurological symptoms in patients with leptomeningeal metastases from breast cancer during intrathecal methotrexate therapy. Aim. To identify clinical and cytological features in patients with leptomeningeal metastases from breast cancer during intrathecal methotrexate therapy. Materials and methods. A retrospective analysis of 30 patients with leptomeningeal metastases from breast cancer who received intrathecal methotrexate in the Department of Neurooncology of the N. N. Blokhin National Medical Research Center of Oncology from 2018 to 2024. Results. All 30 cases involved women with ductal or lobular breast cancer. The highest proportion of patients with leptomeningeal metastases were found in stage III–C breast cancer (33.3 %). Cytological analysis of cerebrospinal fluid and neurological status assessment were performed before each methotrexate administration. The correlation was monitored throughout the treatment period. A direct statistically significant relationship has been found between the number of tumor cells in cerebrospinal fluid and the severity of neurological disorders: at one month after treatment start r = 0.702; p = 0.000 and at two months r = 0.819; p = 0.000. However, prior to therapy initiation there was no correlation between these parameters (r = 0.056; p = 0.770). Thus, with a low level of tumor cytosis pronounced neurological symptoms could be present (75 cells, symptom score – 6 points), while conversely, with an elevated cytosis level mild neurological manifestations might occur (400 cells, symptom score – 3 points). It was found that only with a decrease in the number of tumor cells in the cerebrospinal fluid by 2 or more times (or by 50 %) does the severity of neurological disorders change. And an increase in the severity of neurological disorders occurs in the case of an increase in the number of cells in the cerebrospinal fluid by 1.2 times (or by 20 %). Moreover, this correlation was maintained throughout the treatment. Conclusion. Evaluation of the dynamics of tumor cytosis in the cerebrospinal fluid, along with clinical characteristics, can be recommended for use in predicting the response to treatment in patients with leptomeningeal metastases of breast cancer.
- Open Access
- 17 December 2025
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 24 (4) , 39-46
Prognostic value of interleukins 6 and 8 in assessing the effectiveness of therapy in patients with triple-negative breast cancer
Background. Interleukin (IL) 6 is a potent proinflammatory pleiotropic cytokine and is a key factor in the immune escape of malignant cells. IL-8 (or CXCL8) is a proinflammatory chemokine, high levels of expression of which were observed in various types of cancer. Aim. To determine the relationship between the level of IL-6 and IL-8 cytokines in the blood serum with the main populations of peripheral blood lymphocytes and its significance for the results of neoadjuvant chemotherapy for triple-negative breast cancer (TN BC). Materials and methods. All 64 patients received chemotherapy and surgery. The concentrations of IL-6 and IL-8 (ng/ml) in the blood serum and the percentage of the main lymphocyte populations in the peripheral blood (PB) were determined. Results. The relationship between progression, metastasis and death of patients with higher IL-6 concentrations in the blood serum of patients with TN BC was demonstrated. Before treatment, a positive correlation was found between the IL-6 level and the percentage of HLA-DR, CD3+HLA-DR+, CD3–HLA-DR+ lymphocytes, which, as previously shown, are negative prognostic factors in TN BC. An increase in the IL-6 level was combined with a decrease in the percentage of CD4+ T lymphocytes. Conclusion. The obtained results are consistent with the position that IL-6 is a negative prognostic factor in patients with BC. The positive relationship between IL-6 and “negative” HLA-DR, CD3+HLA-DR+, CD3‒HLA-DR+ lymphocyte populations found in the work indicates their interaction in stimulating tumor growth.
- 17 December 2025
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 24 (4) , 39-46
Open AccessPrognostic value of interleukins 6 and 8 in assessing the effectiveness of therapy in patients with triple-negative breast cancer
Background. Interleukin (IL) 6 is a potent proinflammatory pleiotropic cytokine and is a key factor in the immune escape of malignant cells. IL-8 (or CXCL8) is a proinflammatory chemokine, high levels of expression of which were observed in various types of cancer. Aim. To determine the relationship between the level of IL-6 and IL-8 cytokines in the blood serum with the main populations of peripheral blood lymphocytes and its significance for the results of neoadjuvant chemotherapy for triple-negative breast cancer (TN BC). Materials and methods. All 64 patients received chemotherapy and surgery. The concentrations of IL-6 and IL-8 (ng/ml) in the blood serum and the percentage of the main lymphocyte populations in the peripheral blood (PB) were determined. Results. The relationship between progression, metastasis and death of patients with higher IL-6 concentrations in the blood serum of patients with TN BC was demonstrated. Before treatment, a positive correlation was found between the IL-6 level and the percentage of HLA-DR, CD3+HLA-DR+, CD3–HLA-DR+ lymphocytes, which, as previously shown, are negative prognostic factors in TN BC. An increase in the IL-6 level was combined with a decrease in the percentage of CD4+ T lymphocytes. Conclusion. The obtained results are consistent with the position that IL-6 is a negative prognostic factor in patients with BC. The positive relationship between IL-6 and “negative” HLA-DR, CD3+HLA-DR+, CD3‒HLA-DR+ lymphocyte populations found in the work indicates their interaction in stimulating tumor growth.
- Open Access
- 1 January 2025
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 46 (1)
Regulatory B cells: role in the immune response to tumor
Регуляторные B-клетки: роль в иммунном ответе на опухоль
- 1 January 2025
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 46 (1)
Open AccessRegulatory B cells: role in the immune response to tumor
Регуляторные B-клетки: роль в иммунном ответе на опухоль
- Open Access
- 5 August 2024
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 29 (8) , 275
Anticancer Plant Secondary Metabolites Induce Linker Histone Depletion from Chromatin
Background: Many plant secondary metabolites (PSMs) were shown to intercalate into DNA helix or interact with DNA grooves. This may influence histone-DNA interactions changeing chromatin structure and genome functioning. Methods: Nucleosome stability and linker histone H1.2, H1.4 and H1.5 localizations were studied in HeLa cells after the treatment with 15 PSMs, which are DNA-binders and possess anticancer activity according to published data. Chromatin remodeler CBL0137 was used as a control. Effects of PSMs were studied using fluorescent microscopy, flowcytometry, quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR), western-blotting. Results: We showed that 1-hour treatment with CBL0137 strongly inhibited DNA synthesis and caused intensive linker histone depletion consistent with nucleosome destabilization. None of PSMs caused nucleosome destabilization, while most of them demonstrated significant influence on linker histone localizations. In particular, cell treatment with 11 PSMs at non-toxic concentrations induced significant translocation of the histone H1.5 to nucleoli and most of PSMs caused depletion of the histones H1.2 and H1.4 from chromatin fraction. Curcumin, resveratrol, berberine, naringenin, and quercetin caused significant redistribution of all three variants of the studied linker histones showing some overlap of PSM effects on linker histone DNA-binding. We demonstrated that PSMs, which induced the most significant redistribution of the histone H1.5 (berberine, curcumin and naringenin), influence the proportion of cells synthesizing DNA, expressing or non-expressing cyclin B and influence cell cycle distribution. Berberine induction of H1.5 translocations to nucleoli was shown to occur independently on the phases of cell cycle (metaphase was not analyzed). Conclusions: For the first time we revealed PSM influence on linker histone location in cell nuclei that opens a new direction of PSM research as anticancer agents.
- 5 August 2024
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 29 (8) , 275
Open AccessAnticancer Plant Secondary Metabolites Induce Linker Histone Depletion from Chromatin
Background: Many plant secondary metabolites (PSMs) were shown to intercalate into DNA helix or interact with DNA grooves. This may influence histone-DNA interactions changeing chromatin structure and genome functioning. Methods: Nucleosome stability and linker histone H1.2, H1.4 and H1.5 localizations were studied in HeLa cells after the treatment with 15 PSMs, which are DNA-binders and possess anticancer activity according to published data. Chromatin remodeler CBL0137 was used as a control. Effects of PSMs were studied using fluorescent microscopy, flowcytometry, quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR), western-blotting. Results: We showed that 1-hour treatment with CBL0137 strongly inhibited DNA synthesis and caused intensive linker histone depletion consistent with nucleosome destabilization. None of PSMs caused nucleosome destabilization, while most of them demonstrated significant influence on linker histone localizations. In particular, cell treatment with 11 PSMs at non-toxic concentrations induced significant translocation of the histone H1.5 to nucleoli and most of PSMs caused depletion of the histones H1.2 and H1.4 from chromatin fraction. Curcumin, resveratrol, berberine, naringenin, and quercetin caused significant redistribution of all three variants of the studied linker histones showing some overlap of PSM effects on linker histone DNA-binding. We demonstrated that PSMs, which induced the most significant redistribution of the histone H1.5 (berberine, curcumin and naringenin), influence the proportion of cells synthesizing DNA, expressing or non-expressing cyclin B and influence cell cycle distribution. Berberine induction of H1.5 translocations to nucleoli was shown to occur independently on the phases of cell cycle (metaphase was not analyzed). Conclusions: For the first time we revealed PSM influence on linker histone location in cell nuclei that opens a new direction of PSM research as anticancer agents.
- Open Access
- 27 July 2024
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 26 (4) , 819-826
Analysis of the lymphoid tumor microenvironment (TILs) in breast cancer by flow cytometry
Despite the success in early diagnosis and drug treatment of breast cancer patients, long-term treatment results are still unsatisfactory, and in this regard, the role of research aimed at studying various mechanisms of development of this disease is increasing. It has been established that the degree of tumor infiltration by immune cells and their composition are directly related to the development of the disease and the response to therapy. Multiparameter flow cytometry (PC) allows studies of the subpopulation composition of TILs. The aim of the work was to study the features of the lymphoid microenvironment (TILs) of tumors in patients with primary operable and locally advanced breast cancer by PC. The study included patients with primary operable breast cancer (group 1, n = 121) and locally advanced (group 2, n = 80) receiving treatment at the N. N. Blokhin NMRCO. The TILs of a tumor obtained intraoperatively or by a core-biopsy were examined. The patients were divided into 3 subgroups: 1 subgroup – the degree of infiltration up to 1%, 2 subgroup – the degree of infiltration from 1 to 10%, and 3 subgroup – the degree of infiltration over 10%. Patients of group 1 were characterized by high functional activity and concentration of effector cells with a low degree of tumor infiltration, and as the number of lymphocytes in the tumor increased, an increase in the pool of CD4+ cells and CD4 Treg was noted simultaneously with a decrease in the number and functional activity of effector TILs. In group 2 were no significant differences in the cellular composition of TILs in subgroups with a weak and moderate degree of infiltration, and a variant with infiltration of more than 10% was recorded in only one patient. The lack of association of the TILs subpopulation structure in subgroups with varying degrees of tumor infiltration indicates a similar nature of the local immune response in locally advanced breast cancer.Thus, unlike patients with locally advanced breast cancer, patients with primary operable breast cancer show a change in the type of local immune response from effector to regulatory. A high degree of tumor infiltration is characterized by depletion of effector cell function.
- 27 July 2024
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 26 (4) , 819-826
Open AccessAnalysis of the lymphoid tumor microenvironment (TILs) in breast cancer by flow cytometry
Despite the success in early diagnosis and drug treatment of breast cancer patients, long-term treatment results are still unsatisfactory, and in this regard, the role of research aimed at studying various mechanisms of development of this disease is increasing. It has been established that the degree of tumor infiltration by immune cells and their composition are directly related to the development of the disease and the response to therapy. Multiparameter flow cytometry (PC) allows studies of the subpopulation composition of TILs. The aim of the work was to study the features of the lymphoid microenvironment (TILs) of tumors in patients with primary operable and locally advanced breast cancer by PC. The study included patients with primary operable breast cancer (group 1, n = 121) and locally advanced (group 2, n = 80) receiving treatment at the N. N. Blokhin NMRCO. The TILs of a tumor obtained intraoperatively or by a core-biopsy were examined. The patients were divided into 3 subgroups: 1 subgroup – the degree of infiltration up to 1%, 2 subgroup – the degree of infiltration from 1 to 10%, and 3 subgroup – the degree of infiltration over 10%. Patients of group 1 were characterized by high functional activity and concentration of effector cells with a low degree of tumor infiltration, and as the number of lymphocytes in the tumor increased, an increase in the pool of CD4+ cells and CD4 Treg was noted simultaneously with a decrease in the number and functional activity of effector TILs. In group 2 were no significant differences in the cellular composition of TILs in subgroups with a weak and moderate degree of infiltration, and a variant with infiltration of more than 10% was recorded in only one patient. The lack of association of the TILs subpopulation structure in subgroups with varying degrees of tumor infiltration indicates a similar nature of the local immune response in locally advanced breast cancer.Thus, unlike patients with locally advanced breast cancer, patients with primary operable breast cancer show a change in the type of local immune response from effector to regulatory. A high degree of tumor infiltration is characterized by depletion of effector cell function.
- Open Access
- 26 June 2024
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 23 (2) , 60-68
The two types of immune microenvironment of renal cancer
Background. The tumor microenvironment can both restrain tumor growth and promote disease progression. Therefore, the study of tumor-infiltrating lymphocytes (TILs) subpopulation composition is an urgent and significant topic.Aim. To characterize the immune microenvironment of renal cancer by flow cytometry.Materials and methods. The study included blood, kidney tumor and normal tissue of the removed kidney of 32 patients with clear cell renal cancer treated at N. N. Blokhin National Medical Research Center of Oncology. Kidney tissue was obtained during surgical removal of the tumor (resection / nephrectomy). A fragment of tumor and normal tissue was taken for analysis under the control of a morphologist. Blood for the study was taken on the day of surgery. Immunologic study was performed by flow cytometry. Kidney tissue was preliminarily homogenized and cell suspension was stained, as well as peripheral blood, with monoclonal antibodies to CD45, CD3, CD4, CD8, CD16+CD56+, CD19, CD28, CD279, CD11b labeled with different fluorochromes.Results. T-lymphocytes and natural killer (NK) cells have a pronounced inverse correlation, which allowed us to distinguish two (n = 32; 18 / 14) variants of tumor immune microenvironment. T-cell variant, with predominance of CD3+CD8+ cells over CD3+CD4+ lymphocytes, and NK cell variant – increase in the number of NK cells with a pronounced decrease in the proportion of T-lymphocytes at the expense of CD3+CD8+ lymphocytes. The two variants are based on the difference of effector link – predominance of cells of innate (NK) or adoptive (CD3+CD8+) immunity. TILs immune profiles also differed in the number of CD8+PD1+ cells – in the T-cell variant their number was 2 times higher than in the NK cell variant. The similar distribution concerned CD4+ Treg cells.Conclusion. Two immunologically competitive variants of renal tumor microenvironment were revealed – T-cell variant, characterized by a greater degree of infiltration and concentration of T-regulatory cells; NK cell variant, with an insignificant degree of infiltration and a pronounced strengthening of the effector link in the tissue and proinflammatory activity of peripheral blood.
- 26 June 2024
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 23 (2) , 60-68
Open AccessThe two types of immune microenvironment of renal cancer
Background. The tumor microenvironment can both restrain tumor growth and promote disease progression. Therefore, the study of tumor-infiltrating lymphocytes (TILs) subpopulation composition is an urgent and significant topic.Aim. To characterize the immune microenvironment of renal cancer by flow cytometry.Materials and methods. The study included blood, kidney tumor and normal tissue of the removed kidney of 32 patients with clear cell renal cancer treated at N. N. Blokhin National Medical Research Center of Oncology. Kidney tissue was obtained during surgical removal of the tumor (resection / nephrectomy). A fragment of tumor and normal tissue was taken for analysis under the control of a morphologist. Blood for the study was taken on the day of surgery. Immunologic study was performed by flow cytometry. Kidney tissue was preliminarily homogenized and cell suspension was stained, as well as peripheral blood, with monoclonal antibodies to CD45, CD3, CD4, CD8, CD16+CD56+, CD19, CD28, CD279, CD11b labeled with different fluorochromes.Results. T-lymphocytes and natural killer (NK) cells have a pronounced inverse correlation, which allowed us to distinguish two (n = 32; 18 / 14) variants of tumor immune microenvironment. T-cell variant, with predominance of CD3+CD8+ cells over CD3+CD4+ lymphocytes, and NK cell variant – increase in the number of NK cells with a pronounced decrease in the proportion of T-lymphocytes at the expense of CD3+CD8+ lymphocytes. The two variants are based on the difference of effector link – predominance of cells of innate (NK) or adoptive (CD3+CD8+) immunity. TILs immune profiles also differed in the number of CD8+PD1+ cells – in the T-cell variant their number was 2 times higher than in the NK cell variant. The similar distribution concerned CD4+ Treg cells.Conclusion. Two immunologically competitive variants of renal tumor microenvironment were revealed – T-cell variant, characterized by a greater degree of infiltration and concentration of T-regulatory cells; NK cell variant, with an insignificant degree of infiltration and a pronounced strengthening of the effector link in the tissue and proinflammatory activity of peripheral blood.
- Open Access
- 10 December 2023
- Published by Consilium Medicum in Journal of Modern Oncology
- Vol. 25 (3) , 301-307
Membrane (CD8⁺PD-1⁺ and CD4+PD-1⁺) and soluble (sPD-1 and sPD-L1) forms of immune checkpoints in melanoma, breast cancer, and oral mucosal cancer patients: A observational study
Background. The PD-1/PD-L1 pathway plays an important role in tumor evasion from immunological surveillance. In addition to the membrane forms of PD-1 and PD-L1, there are soluble variants: sPD-1 and sPD-L1. Both membrane and soluble forms have immunoregulatory properties and can affect the function and number of different immune cell populations. Aim. To study the relationship between the initial level of CD8⁺PD-1⁺ and CD4+PD-1⁺ lymphocytes and soluble forms of sPD-1 and sPD-L1 with the percentage of the main effector and regulatory populations of peripheral blood (PB) lymphocytes and tumor-infiltrating lymphocytes. Materials and methods. The study included melanoma, breast cancer and the oral mucosa cancer patients. The percentage of cell populations of PB lymphocytes and tumor-infiltrating lymphocytes was determined by flow cytometry before treatment. The concentrations of sPD-1 and sPD-L1 proteins were studied in blood serum using enzyme immunoassay. Results. The relationship of the level of CD8⁺PD-1⁺ cells with certain populations of CD8-lymphocytes in PB and tumor tissue was found. In the PB of melanoma patients with CD8⁺CD11b⁺CD28⁺ and CD8⁺CD11b⁻CD28⁻ T cells, in breast cancer patients with a population of CD8⁺CD11b⁺CD28⁺ lymphocytes. In the tumor tissue of all patients there was a positive correlation with a population of regulatory CD8⁺CD11b⁻CD28⁻ T cells. The immunoregulatory properties of sPD-1 and sPD-L1 were confirmed. Both sPD-1 and sPD-L1 levels were positively correlated with the number of suppressor CD8⁺CD11b⁻CD28⁻ T cells and negatively with the level of CD8 lymphocytes, CD8⁺CD11b⁺CD28⁺ cytotoxic/memory T cells, B cells and activated CD25 lymphocytes. Conclusion. The results of the study can make a certain contribution to the study of the prognostic significance of membrane and soluble forms of PD-1 and PD-L1, taking into account the peculiarities of their relationship with suppressor and effector populations of lymphocytes of systemic and local immunity.
- 10 December 2023
- Published by Consilium Medicum in Journal of Modern Oncology
- Vol. 25 (3) , 301-307
Open AccessMembrane (CD8⁺PD-1⁺ and CD4+PD-1⁺) and soluble (sPD-1 and sPD-L1) forms of immune checkpoints in melanoma, breast cancer, and oral mucosal cancer patients: A observational study
Background. The PD-1/PD-L1 pathway plays an important role in tumor evasion from immunological surveillance. In addition to the membrane forms of PD-1 and PD-L1, there are soluble variants: sPD-1 and sPD-L1. Both membrane and soluble forms have immunoregulatory properties and can affect the function and number of different immune cell populations. Aim. To study the relationship between the initial level of CD8⁺PD-1⁺ and CD4+PD-1⁺ lymphocytes and soluble forms of sPD-1 and sPD-L1 with the percentage of the main effector and regulatory populations of peripheral blood (PB) lymphocytes and tumor-infiltrating lymphocytes. Materials and methods. The study included melanoma, breast cancer and the oral mucosa cancer patients. The percentage of cell populations of PB lymphocytes and tumor-infiltrating lymphocytes was determined by flow cytometry before treatment. The concentrations of sPD-1 and sPD-L1 proteins were studied in blood serum using enzyme immunoassay. Results. The relationship of the level of CD8⁺PD-1⁺ cells with certain populations of CD8-lymphocytes in PB and tumor tissue was found. In the PB of melanoma patients with CD8⁺CD11b⁺CD28⁺ and CD8⁺CD11b⁻CD28⁻ T cells, in breast cancer patients with a population of CD8⁺CD11b⁺CD28⁺ lymphocytes. In the tumor tissue of all patients there was a positive correlation with a population of regulatory CD8⁺CD11b⁻CD28⁻ T cells. The immunoregulatory properties of sPD-1 and sPD-L1 were confirmed. Both sPD-1 and sPD-L1 levels were positively correlated with the number of suppressor CD8⁺CD11b⁻CD28⁻ T cells and negatively with the level of CD8 lymphocytes, CD8⁺CD11b⁺CD28⁺ cytotoxic/memory T cells, B cells and activated CD25 lymphocytes. Conclusion. The results of the study can make a certain contribution to the study of the prognostic significance of membrane and soluble forms of PD-1 and PD-L1, taking into account the peculiarities of their relationship with suppressor and effector populations of lymphocytes of systemic and local immunity.